# Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate

> **NCT03644576** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 54 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ozanimod
- **DRUG:** Pseudoephedrine
- **DRUG:** ozanimod placebo

## Key facts

- **NCT ID:** NCT03644576
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-11
- **Primary completion:** 2018-09-12
- **Final completion:** 2018-09-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03644576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03644576, "Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03644576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*